The Therapeutic Potential of Supersulfides in Oxidative Stress-Related Diseases

Yuexuan Pan1, Tetsuro Matsunaga2, Tianli Zhang2

  • 1Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.

Biomolecules
|February 26, 2025
PubMed

Insights

Emerging supersulfides offer novel antioxidant mechanisms to combat oxidative stress and related diseases. This review explores their role in redox homeostasis and therapeutic potential for conditions like cancer and neurodegeneration.

Area of Science:

  • Redox biology
  • Molecular and cellular biology

Background:

  • Oxidation-reduction (redox) reactions are vital for life, regulating cellular signaling and homeostasis.
  • Imbalances in redox state, or oxidative stress, contribute to diseases like cancer, neurodegeneration, and inflammatory disorders.
  • Current antioxidant therapies show limited clinical efficacy for oxidative stress-related conditions.

Purpose of the Study:

  • To review the emerging concept of supersulfides as novel redox regulators.
  • To highlight the roles of supersulfides in cellular redox homeostasis and oxidative stress.
  • To discuss the therapeutic potential of supersulfides for treating diseases linked to redox imbalance.

Main Methods:

  • Literature review of supersulfides in redox biology.
  • Analysis of supersulfide mechanisms in cellular homeostasis.
  • Evaluation of therapeutic strategies involving synthetic supersulfides.

Main Results:

  • Supersulfides possess unique antioxidant and nucleophilic properties.
  • They act as crucial regulators of cellular redox homeostasis.
  • Supersulfides offer novel therapeutic avenues distinct from traditional antioxidants.

Conclusions:

  • Supersulfides represent a promising class of molecules for addressing oxidative stress.
  • Understanding supersulfide function can drive the development of innovative redox-based therapies.
  • Targeting redox regulation holds potential for preventing and treating numerous diseases.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.1K
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
35
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
15.9K